Nick Ertl > Elkington + Fife LLP > Sevenoaks, England > Lawyer Profile

Elkington + Fife LLP
Nick Ertl photo

Work Department

UK and European patent attorney




Nick has 20 years experience in the drafting of patent applications and their prosecution around the world, especially before the EPO. He is entrusted by numerous large multinational corporations to prepare patent applications in the fields of semiconductor electronics, general electronics hardware, optical components and systems. Nick is always excited to work in areas of technology new to him, and to invest his own time to become familiar with the underlying science involved. As a result, he has worked in many diverse areas of technology over the years. Specialist technical fields include: audio-visual technology; communications; electrical devices and electronics; mechanical engineering; semiconductors. Areas of expertise include: filing and prosecution; freedom to operate opinions; patent drafting; validity and infringement opinions.


English, French


University of Nottingham (M.Eng).

Lawyer Rankings

London > TMT (technology, media and telecoms) > PATMA: Patent attorneys

Demonstrating its continued capability and success in EPO opposition and appeal proceedings, Elkington + Fife LLP is ‘efficient, knowledgeable and experienced in the pharmaceutical and life sciences sectors’, and advises its roster of clients on patent prosecution matters. The team counts biotechnology mandates in its workload, as well as patent drafting for multinational companies, such as Philips and IBM, in the electronics field. From the firm’s office in London, senior partner Richard Gillard leads the chemistry and life sciences group, and is the firm’s key contact for EPO opposition and appeals work, while Sevenoaks-based Nick Ertl heads up the electrical and mechanical team, and has experience in drafting patent applications, particularly for corporate clients. London-based Jens Grabenstein is another key member of the team, who assists biotechnology companies in building their patent portfolios.